Dr. Bhavesh Barad, MD
What this data tells you about Dr. Barad
Dr. Bhavesh Barad is a cardiovascular disease in Lecanto, FL, with 16 years in practice. Based on federal Medicare data, Dr. Barad performed 7,817 Medicare services across 5,131 unique beneficiaries.
Between the years covered by Open Payments, Dr. Barad received a total of $3,986 from 26 pharmaceutical and/or device companies across 152 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Barad is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,090 | $93 | $254 |
| Regadenoson injection (Lexiscan) for heart stress test | 581 | $42 | $237 |
| Hospital follow-up visit, moderate complexity | 511 | $62 | $159 |
| Electrocardiogram (EKG), 12-lead | 468 | $11 | $29 |
| Office visit, established patient (20-29 min) | 365 | $65 | $179 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 355 | $88 | $320 |
| Initial hospital admission, high complexity | 323 | $136 | $351 |
| Echocardiogram, transthoracic | 249 | $140 | $380 |
| Blood draw (venipuncture) | 246 | $8 | $16 |
| Hospital follow-up visit, high complexity | 232 | $93 | $239 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 210 | $48 | $138 |
| Prothrombin time test (blood clotting) | 207 | $4 | $9 |
| Anticoagulant management of patient taking warfarin | 201 | $8 | $23 |
| Remote pacemaker/defibrillator monitoring, 90 days | 198 | $15 | $43 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 178 | $327 | $847 |
| Remote pacemaker monitoring, 90 days | 154 | $20 | $60 |
| New patient office visit (45-59 min) | 151 | $119 | $333 |
| Office visit, established patient, complex (40-54 min) | 140 | $132 | $357 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 140 | $27 | $143 |
| Lipid panel (cholesterol and triglycerides) | 130 | $13 | $27 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 127 | $51 | $141 |
| Initial hospital admission, moderate complexity | 117 | $99 | $263 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 93 | $20 | $53 |
| Ultrasound of both sides of head and neck blood flow | 91 | $136 | $372 |
| Magnesium level test | 85 | $7 | $14 |
| Comprehensive metabolic blood panel | 84 | $10 | $21 |
| Natriuretic peptide (heart and blood vessel protein) level | 75 | $38 | $79 |
| Remote patient monitoring device, 30 days | 73 | $37 | $95 |
| Remote patient monitoring management, 20 min/month | 69 | $37 | $96 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 63 | $312 | $491 |
| Lipoprotein (a) level | 61 | $14 | $29 |
| Basic metabolic blood panel | 56 | $8 | $17 |
| Complete blood count (CBC) with differential | 47 | $8 | $16 |
| Ultrasound of leg arteries or artery grafts | 46 | $169 | $465 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 45 | $25 | $73 |
| Ultrasound of heart with probe in esophagus, with report | 39 | $83 | $211 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 39 | $2 | $6 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 38 | $43 | $110 |
| Ultrasound of heart blood flow, valves and chambers | 38 | $14 | $37 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 38 | $10 | $26 |
| Nuclear medicine study of heart muscle blood flow by pet | 29 | $139 | $459 |
| Heart muscle strain imaging | 28 | $28 | $72 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 26 | $20 | $51 |
| Critical care, first 30-74 min | 26 | $170 | $444 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 25 | $407 | $1,076 |
| Ultrasound of aorta, vena cava, groin vessels or bypass grafts | 25 | $85 | $228 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 23 | $611 | $1,601 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 23 | $136 | $366 |
| New patient office visit (30-44 min) | 22 | $77 | $225 |
| Ultrasound scan of abdominal aorta | 19 | $102 | $208 |
| New patient office visit, complex (60-74 min) | 19 | $154 | $440 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 18 | $2,094 | $5,550 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 16 | $14 | $37 |
| Insertion of heart rhythm monitor under skin | 14 | $3,252 | $8,388 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 14 | $1,140 | $3,948 |
| Thyroid stimulating hormone (TSH) test | 14 | $16 | $34 |
| Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 12 | $268 | $684 |
| External shock to heart to regulate heart beat | 11 | $85 | $217 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
7.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Barad is a clinical cardiology specialist, with above-average Medicare volume (top 11% in FL), and low-engagement industry engagement, with 16 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Barad experienced with office visit, established patient (30-39 min)?
Does Dr. Barad receive payments from pharmaceutical companies?
How do Dr. Barad's costs compare to other cardiovascular diseases in Lecanto?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology